Mankind Pharma IPO GMP, Mankind Pharma Grey Market Premium Today
Mankind Pharma IPO: Mankind Pharma IPO GMP (Mankind Pharma Grey Market Premium), Mankind Pharma Limited IPO Date, Mankind Pharma Ltd IPO Review and Rating for Short term and long-term. We will update Mankind Pharma GMP daily. Stay tuned with us for Mankind Pharma Limited IPO GMP and other important updates.
Mankind Pharma IPO Details
Mankind Pharma Ltd Has filed its DRHP (Draft Red Herring Prospectus) with market regulator SEBI (Securities and Exchange Board of India) to raise around Rs 4326 crore through IPO (Initial public offering).
Mankind Pharma IPO opening Date is 25 April 2023 and the closing date is 27 April 2023. Mankind Pharma IPO Price band is ₹1026 to ₹1080. Mankind Pharma Limited IPO size is 4326 Crores. Mankind Pharma IPO QIB quota is 50%, NII quota is 15% and RII quota is 35%. Mankind Pharma IPO will list on 08 May 2022. You can know about Mankind Pharma IPO GMP (Grey Market Premium) below.
You can also know about Mankind Pharma's limited financial details i.e. Total assets, Revenue, and Profit after tax. The company made a profit of ₹1452.96 crores in the financial year 2022 The IPO of Mankind Pharma will be listed on NSE and BSE. Mankind Pharma IPO face value is ₹1 per equity share.
We will talk about Mankind Pharma's financials, benefits, and risks of investing in the company. You can see All information about Mankind Pharma IPO GMP, Kostak rate, and subject to sauda rates below.
Mankind Pharma GMP Today (Grey Market Premium)
| DATE | GMP | KOSTAK | Subject to Sauda |
|---|---|---|---|
| 30 April | ₹ | ₹ | ₹ |
| 29 April | ₹ | ₹ | ₹ |
| 28 April | ₹ | ₹ | ₹ |
| 27 April | ₹40 | ₹500 | ₹750 |
| 26 April | ₹70 | ₹500 | ₹750 |
| 25 April | ₹70 | ₹500 | ₹750 |
| 24 April | ₹90 | ₹500 | ₹1000 |
| 23 April | ₹90 | ₹500 | ₹1000 |
| 22 April | ₹90 | ₹500 | ₹1000 |
| 21 April | ₹90 | ₹- | ₹- |
| 20 April | ₹90 | ₹- | ₹- |
| 19 April | ₹100 | ₹- | ₹- |
| 18 April | ₹100 | ₹- | ₹- |
| 17 April | ₹100 | ₹- | ₹- |
| 16 April | ₹100 | ₹- | ₹- |
| 15 April | ₹100 | ₹- | ₹- |
| 14 April | ₹100 | ₹- | ₹- |
Mankind Pharma IPO Date and Price Band Details
| IPO Open: | 25 April 2023 |
| IPO Close: | 27 April 2023 |
| Listing Date: | 08 May 2023 |
| Listing On: | NSE & BSE |
| IPO Size: | Approx ₹4,326 crores |
| Fresh Issue: | Approx ₹- crores |
| Offer For Sale: | Approx ₹4,326 crores |
| Price Band: | ₹1026 to ₹1080 per share |
| Face Value: | ₹10 per Equity share |
| QIB Portion: | 50% |
| Retail Portion: | 35% |
| NII Portion: | 15% |
| Employee Res: | Not Disclosed |
Mankind Pharma IPO Lot Size Details
| Minimum Lot: | 01 |
| Minimum Lot Size: | 13 Shares |
| Minimum Amount: | ₹14,040 |
| Maximum Lot: | 13 |
| Maximum Lot Size: | 182 Shares |
| Maximum Amount: | ₹196,560 |
Mankind Pharma IPO Open, Close, Allotment, and Listing Date
| Ipo Opening Date: | 25 April 2023 |
| IPO Closing Date: | 27 April 2023 |
| Basis of Allotment: | 03 May 2023 |
| Refund Date: | 04 May 2023 |
| Credit to Demat Account: | 05 May 2023 |
| Listing Date: | 08 May 2023 |
Mankind Pharma IPO Review
| Happiest Post | Apply |
| Anand Rathi | Not Rated yet |
| Angle One | Not Rated yet |
| Axis Capital | Not Rated yet |
| HDFC Securities | Not Rated yet |
| ICICI Direct | Apply |
| Kotak Securities | Not Rated yet |
| Motilal Oswal | Not Rated yet |
| Sharekhan | Not Rated yet |
You can also check the latest IPO subscription status and IPO allotment status of Mankind Pharma IPO on our website.
Promoters
- Ramesh Juneja, Rajeev Juneja
- Sheetal Arora
- Ramesh Juneja Family Trust
- Rajeev Juneja Family Trust
- Prem Sheetal Family Trust
Contact Details of Mankind Pharma
208, Okhla Industrial Estate
Phase-III,
New Delhi 110020, India
Telephone: +91 11 4684 6700
E-mail: investors@mankindpharma.com
Website:https://www.mankindpharma.com/
Mankind Pharma Lead Managers
- IIFL Securities Limited
- Kotak Mahindra Capital Company Limited
- Axis Capital Limited
- J.P. Morgan India Private Limited
- Jefferies India Private Limited
Mankind Pharma IPO Registrars
Telephone: Phone: 04067162222, 04079611000
Email: mankind.ipo@kfintech.com
Website:https://karisma.kfintech.com/
Conclusion
The GMP (Grey Market Premium), Kostak Rate, and Subject Rate of Mankind Pharma IPO are given in the above table. The track record has been good considering the financial position of the company. The company had a profit of Rs 1452.96 crore in the financial year 2022. Our suggestion will be updated when Mankind Pharma Limited IPO starts. Given above is the brokerage review of Mankind Pharma Limited IPO and other information. Click here to know the strength, risk, and financial details of Mankind Pharma IPO.
Mankind Pharma IPO FAQs
How to Apply the Mankind Pharma Ltd IPO with Zerodha?
Disclaimer
- We are not involved in gray market trading in any way. And do not provide the facility to buy or sell any IPO from IPO.
- Reference to IPO Grey Market Premium (IPO GMP) is valid only for the date specified in the header.
- We are not involved in the buying or selling of IPO forms.
- Do not decide to subscribe to an IPO solely based on GMP (Grey Market Premium), as this can change at any time. Research the fundamentals and financial statements of companies before subscribing.
We hope you like this article about Electronics Mart India IPO GMP (Gray Market Premium). If you have a query about Electronics Mart India IPO GMP then, leave a comment. Here you can also stay updated about the IPO Allotment Status and upcoming IPO. Also, you can track IPO performance. You can use the Stock Average Calculator and SIP Calculator for free of cost. Thanks for Visiting. Happy Investing.
0 Comments
We are waiting for your comments. 💙